2901 - 2950 of 8399 Results
Title
Year
-
OPENTitle: North American survey on impact of the COVID-19 pandemic shutdown on DBS careJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 41End Page: 45Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.011Best OA location URL: http://www.prd-journal.com/article/S1353802021003667/pdfCitation Count: 7
- Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases2021OPENTitle: Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseasesJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 1Start Page: 27End Page: 44Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/brain/awab404Best OA location URL: https://academic.oup.com/brain/article-pdf/145/1/27/43246591/awab404.pdfCitation Count: 77
- White matter changes in drug-naïve Parkinson's disease patients with impulse control & probable REM sleep behavior disorders2021RESTRICTEDTitle: White matter changes in drug-naïve Parkinson's disease patients with impulse control & probable REM sleep behavior disordersJournal Name: Journal of the Neurological SciencesPublisher: Elsevier BVVol: 430Issue #:Start Page: 120032End Page: 120032Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jns.2021.120032Citation Count: 7
- Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome2021OPENTitle: Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2129397End Page: e2129397Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.29397Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2785081/coffey_2021_oi_210860_1633624168.09.pdfCitation Count: 30
- Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brain2021OPENTitle: Pathogenic LRRK2 control of primary cilia and Hedgehog signaling in neurons and astrocytes of mouse brainJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 10Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.7554/elife.67900Best OA location URL: https://doi.org/10.7554/elife.67900Citation Count: 75
- Glucocerebrosidase 1 and leucine‐rich repeat kinase 2 in Parkinson disease and interplay between the two genes2021RESTRICTEDTitle: Glucocerebrosidase 1 and leucine‐rich repeat kinase 2 in Parkinson disease and interplay between the two genesJournal Name: Journal of NeurochemistryPublisher: WileyVol: 159Issue #: 5Start Page: 826End Page: 839Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1111/jnc.15524Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.15524Citation Count: 7
-
OPENTitle: Safety of AADC Gene Therapy for Moderately Advanced Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 98Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000012952Best OA location URL: https://n.neurology.org/content/neurology/98/1/e40.full.pdfCitation Count: 54
- A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative Study2021OPENTitle: A Patient-Centered Conceptual Model of Symptoms and Their Impact in Early Parkinson’s Disease: A Qualitative StudyJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 137End Page: 151Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-202457Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd202457?id=journal-of-parkinsons-disease%2Fjpd202457Citation Count: 28
-
OPENTitle: An Expanded Polyproline Domain Maintains Mutant Huntingtin Soluble in vivo and During AgingJournal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2021.721749Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2021.721749/pdfCitation Count: 13
-
OPENTitle: Small Molecule Improvement of Trafficking Defects in Models of NeurodegenerationJournal Name: ACS Chemical NeurosciencePublisher: American Chemical Society (ACS)Vol: 12Issue #: 21Start Page: 3972End Page: 3984Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754116Citation Count: 1
-
OPENTitle: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00239-xBest OA location URL: https://www.nature.com/articles/s41531-021-00239-x.pdfCitation Count: 42
-
OPENTitle: CD4 + T cells contribute to neurodegeneration in Lewy body dementiaJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6569Start Page: 868End Page: 874Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1126/science.abf7266Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9122025Citation Count: 142
- Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuum2021OPENTitle: Contribution of Alzheimer's biomarkers and risk factors to cognitive impairment and decline across the Alzheimer's disease continuumJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 7Start Page: 1370End Page: 1382Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12480Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9014819Citation Count: 29
- KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alzheimer’s Disease2021OPENTitle: KYNA/Ahr Signaling Suppresses Neural Stem Cell Plasticity and Neurogenesis in Adult Zebrafish Model of Alzheimer’s DiseaseJournal Name: CellsPublisher: MDPI AGVol: 10Issue #: 10Start Page: 2748End Page: 2748Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells10102748Best OA location URL: https://www.mdpi.com/2073-4409/10/10/2748/pdf?version=1634205316Citation Count: 16
-
RESTRICTEDTitle: Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.010Citation Count: 9
-
OPENTitle: The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril endsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25966-wBest OA location URL: https://www.nature.com/articles/s41467-021-25966-w.pdfCitation Count: 58
- Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medications2021OPENTitle: Validation and clinical value of the MANAGE-PD tool: A clinician-reported tool to identify Parkinson's disease patients inadequately controlled on oral medicationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 59End Page: 66Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.009Best OA location URL: http://www.prd-journal.com/article/S1353802021003643/pdfCitation Count: 39
- Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes2021OPENTitle: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomesJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00513-5Best OA location URL: https://www.nature.com/articles/s41746-021-00513-5.pdfCitation Count: 76
- Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)2021OPENTitle: Generation of two human induced pluripotent stem cell lines from fibroblasts of unrelated Parkinson’s patients carrying the G2019S mutation in the LRRK2 gene (LCSBi005, LCSBi006)Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 57Issue #:Start Page: 102569End Page: 102569Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.scr.2021.102569Best OA location URL: https://doi.org/10.1016/j.scr.2021.102569Citation Count: 2
- Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's Disease2021OPENTitle: Lower Circulating Lymphocyte Count Predicts ApoEε4‐Related Cognitive Decline in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2969End Page: 2971Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28799Best OA location URL: https://repository.kulib.kyoto-u.ac.jp/dspace/bitstream/2433/266630/1/mds.28799.pdfCitation Count: 12
-
RESTRICTEDTitle: Parkinson's Disease and Type 2 Diabetes: HbA1c Is Associated with Motor and Cognitive SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 427End Page: 428Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28829Citation Count: 8
-
OPENTitle: T lymphocyte senescence is attenuated in Parkinson’s diseaseJournal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 18Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s12974-021-02287-9Best OA location URL: https://jneuroinflammation.biomedcentral.com/track/pdf/10.1186/s12974-021-02287-9Citation Count: 29
-
RESTRICTEDTitle: A Summary of Phenotypes Observed in the In Vivo Rodent Alpha-Synuclein Preformed Fibril ModelJournal Name: Journal of Parkinson's DiseasePublisher: IOS PressVol: 11Issue #: 4Start Page: 1555End Page: 1567Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212847Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212847?id=journal-of-parkinsons-disease%2Fjpd212847Citation Count: 22
- Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic Stimulations2021RESTRICTEDTitle: Exploring the Use of Intracranial and Extracranial (Remote) Photobiomodulation Devices in Parkinson’s Disease: A Comparison of Direct and Indirect Systemic StimulationsJournal Name: Journal of Alzheimer's DiseasePublisher: IOS PressVol: 83Issue #: 4Start Page: 1399End Page: 1413Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jad-210052Citation Count: 20
- Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligases2021OPENTitle: Predicting PY motif-mediated protein-protein interactions in the Nedd4 family of ubiquitin ligasesJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0258315End Page: e0258315Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0258315Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0258315&type=printableCitation Count: 15
-
OPENTitle: A Novel Variant of ATP5MC3 Associated with Both Dystonia and Spastic ParaplegiaJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 375End Page: 383Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28821Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8840961Citation Count: 13
-
OPENTitle: Lack of progression of beta dynamics after long‐term subthalamic neurostimulationJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 8Issue #: 11Start Page: 2110End Page: 2120Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/acn3.51463Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607445Citation Count: 24
- Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s Disease2021OPENTitle: Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson’s DiseaseJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 12Issue #: 1Start Page: 267End Page: 282Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-212851Best OA location URL: https://repository.ubn.ru.nl//bitstream/handle/2066/248871/248871.pdfCitation Count: 46
-
RESTRICTEDTitle: Antimuscarinic Anticholinergic Medications in Parkinson Disease: To Prescribe or Deprescribe?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 8Start Page: 1181End Page: 1188Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13347Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13347Citation Count: 19
- Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costs2021OPENTitle: Early subthalamic nucleus deep brain stimulation in Parkinson’s disease reduces long-term medication costsJournal Name: Clinical Neurology and NeurosurgeryPublisher: Elsevier BVVol: 210Issue #:Start Page: 106976End Page: 106976Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.clineuro.2021.106976Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608728Citation Count: 9
- Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption2021OPENTitle: Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruptionJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-26066-5Best OA location URL: https://www.nature.com/articles/s41467-021-26066-5.pdfCitation Count: 164
- Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's Disease2021RESTRICTEDTitle: Platelet Behavior Contributes to Neuropathologies: A Focus on Alzheimer's and Parkinson's DiseaseJournal Name: Seminars in Thrombosis and HemostasisPublisher: Georg Thieme Verlag KGVol: 48Issue #: 03Start Page: 382End Page: 404Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1055/s-0041-1733960Citation Count: 5
-
RESTRICTEDTitle: Population-specific neuromodulation prolongs therapeutic benefits of deep brain stimulationJournal Name: SciencePublisher: American Association for the Advancement of Science (AAAS)Vol: 374Issue #: 6564Start Page: 201End Page: 206Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1126/science.abi7852Citation Count: 122
-
RESTRICTEDTitle: Visual dysfunction is associated with cognitive impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 22End Page: 25Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.005Citation Count: 11
- Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s disease2021OPENTitle: Biomarkers of neurodegeneration and glial activation validated in Alzheimer’s disease assessed in longitudinal cerebrospinal fluid samples of Parkinson’s diseaseJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 16Issue #: 10Start Page: e0257372End Page: e0257372Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0257372Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0257372&type=printableCitation Count: 35
- Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models2021OPENTitle: Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease modelsJournal Name: JCI InsightPublisher: American Society for Clinical InvestigationVol: 6Issue #: 19Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1172/jci.insight.148649Best OA location URL: http://insight.jci.org/articles/view/148649/files/pdfCitation Count: 7
-
RESTRICTEDTitle: New Insights from a Two-Country Study Comparing Escalation Strategies for MS DrugsJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 10End Page: 11Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797988.61856.80Citation Count: 0
-
RESTRICTEDTitle: Then and Now: 20 Years of Monumental Strides in Movement DisordersJournal Name: Neurology TodayPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 21Issue #: 19Start Page: 8End Page: 10Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/01.nt.0000797984.85450.f1Citation Count: 0
-
RESTRICTEDTitle: Apolipoprotein E Genotype Contributes to Motor Progression in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 196End Page: 200Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28805Citation Count: 27
- Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology2021OPENTitle: Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathologyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 3Start Page: 1001End Page: 1017Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awab374Best OA location URL: https://academic.oup.com/brain/article-pdf/145/3/1001/43500027/awab374.pdfCitation Count: 20
-
RESTRICTEDTitle: Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase ActivityJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 12Start Page: 2719End Page: 2730Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28815Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28815Citation Count: 22
-
OPENTitle: Genetic Stratification of Age‐Dependent Parkinson's Disease Risk by Polygenic Hazard ScoreJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 62End Page: 69Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28808Best OA location URL: https://www.duo.uio.no/bitstream/10852/89465/2/Genetic%2bStratification%2bof%2bAge-Dependent%2bParkinson%2527s%2bDisease%2bRisk%2bby%2bPolygenic%2bHazard%2bScore.pdfCitation Count: 15
-
RESTRICTEDTitle: Increased functional connectivity in a population at risk of developing Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 1End Page: 6Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.09.026Citation Count: 6
- LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neurons2021OPENTitle: LGALS3 (galectin 3) mediates an unconventional secretion of SNCA/α-synuclein in response to lysosomal membrane damage by the autophagic-lysosomal pathway in human midbrain dopamine neuronsJournal Name: AutophagyPublisher: Informa UK LimitedVol: 18Issue #: 5Start Page: 1020End Page: 1048Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/15548627.2021.1967615Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/15548627.2021.1967615?needAccess=trueCitation Count: 41
- A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalography2021OPENTitle: A novel approach to understanding Parkinsonian cognitive decline using minimum spanning trees, edge cutting, and magnetoencephalographyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-99167-2Best OA location URL: https://www.nature.com/articles/s41598-021-99167-2.pdfCitation Count: 3
-
OPENTitle: Fine-mapping of Parkinson’s disease susceptibility loci identifies putative causal variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: 6Start Page: 888End Page: 900Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1093/hmg/ddab294Best OA location URL: https://academic.oup.com/hmg/article-pdf/31/6/888/42993647/ddab294.pdfCitation Count: 32
- Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning Analysis2021OPENTitle: Glia Imaging Differentiates Multiple System Atrophy from Parkinson's Disease: A Positron Emission Tomography Study with [11C]PBR28 and Machine Learning AnalysisJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 119End Page: 129Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28814Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28814Citation Count: 24
- Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome2021OPENTitle: Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette SyndromeJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 4Issue #: 10Start Page: e2128204End Page: e2128204Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2021.28204Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2784765/jankovic_2021_oi_210819_1632849263.95.pdfCitation Count: 31
- Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s disease2021RESTRICTEDTitle: Associations of sleep disorders with cerebrospinal fluid α-synuclein in prodromal and early Parkinson’s diseaseJournal Name: Journal of NeurologyPublisher: Springer Science and Business Media LLCVol: 269Issue #: 5Start Page: 2469End Page: 2478Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1007/s00415-021-10812-2Citation Count: 22
- European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulation2021RESTRICTEDTitle: European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part IV: deep brain stimulationJournal Name: European Child & Adolescent PsychiatryPublisher: Springer Science and Business Media LLCVol: 31Issue #: 3Start Page: 443End Page: 461Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1007/s00787-021-01881-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s00787-021-01881-9.pdfCitation Count: 33